Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Randomized, Open-label, Three-arm Study on the Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in the Treatment and Relapse Prophylaxis of Clostridioides Difficile Infection. STOP-CDI Study

NCT07120490 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT07120490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Randomized, Open-label, Three-arm Study on the Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in the Treatment and Relapse Prophylaxis of Clostridioides Difficile Infection. STOP-CDI Study
Lead sponsor
Medical University of Warsaw
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2025
Completion date
April 30, 2027
Enrollment
424 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clostridioides difficile infection, clostridioides difficile infection recurrence, comparative effectiveness of cdi treatments, fecal microbiota transplantation (fmt), fidaxomicin, vancomycin